Does it make sense to continue to spend on a U.S. sales force when insurance coverage influences what brand of IPE a patient receives?
It’s not that Amarin has stopped spending its precious cash resources, they’re just trying to spend it where it can has a direct impact on the bottom line.
Market Data 
Markets 
AI
